From: Fauci, Anthony (NIH/NIAID) [E]

Sent: Mon, 4 May 2020 21:05:39 +0000
To: Conrad, Patricia (NIH/NIAID) [E]
Subject: FW: Invitation to join (virtually) the ACTIV Leadership Meeting 5/6

Please see me about this.

Anthony S. Fauci, MD

Director

National Institute of Allergy and Infectious Diseases
Building 31, Room 7A-03

31 Center Drive, MSC 2520

National Institutes of Health

Bethesda, MD 20892-2520

Phone: __(d)(

FAX: (301) 496-4409

E-mail: [
The information in this > mail and any of its attachments is confidential and may contain sensitive
information. It should not be used by anyone who is not the original intended recipient. If you
have received this e-mail in error please inform the sender and delete it from your mailbox or any
other storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall not
accept liability for any statements made that are the sender's own and not expressly made on
behalf of the NIAID by one of its representatives.

 

From: Collins, Francis (NIH/OD) [E]Z—_ CO) >

Sent: Monday, May 4, 2020 11:18 AM

To: ICDDIR-L@LIST.NIH.GOV

Cc: Parker, Ashley (NIH/OD) (EJZ YJ; Wholley, David (FNIH) [T]
CO) }>; Melencio, Cheryl (FNIH) (TIO S>

Subject: Invitation to join (virtually) the ACTIV Leadership Meeting 5/6

Dear Colleagues,

As you may be aware, the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) public-
private partnership has been moving forward rapidly to address the global pandemic. We held our

initial ACTIV leadership meeting on April 3rd including, NIH, FDA, BARDA, EMA, and industry heads of
research and development. Four working groups were formed out of this meeting to focus on
preclinical therapeutics, clinical therapeutics, clinical trial capacity, and vaccines.

Although some ICs have representatives participating in the working groups, we recognize there is a
need to keep everyone looped in to the various activities and progress of the partnership, particularly in
view of all of the concurrent IC projects about COVID-19. The ACTIV working groups will be delivering
their second report to the ACTIV Leadership Group on Wednesday, May 6, from 3:30-5:00pm. Iam
writing to invite the ICDs to listen-in on this meeting. There will be a lot to cover during the meeting and
the members of the Leadership Group will be asking the questions. But to give a chance for us NlHers to
